Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-7-1
|
pubmed:abstractText |
We have investigated the efficiency and safety of large volume leukapheresis (LVL) for the collection of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells (PBPCs) from healthy donors. In six apheresis sessions in four healthy individuals on a COBE-BCT Spectra cell separator (median processed volume 3.5 X total blood volume, TBV, range 3.3-4.4 X TBV), harvested cells were collected sequentially into three single bags. The collection bags were changed after processing 33%, 66%, and 100% of the prospective apheresis volume, allowing analysis of PBPCs collected at different periods during one harvest. Mononuclear cells (MNCs), CD34+ cells, CD34+ subsets, and lymphocyte subsets were determined in each bag. Substantially more PBPCs were harvested than were in the circulation before G-CSF administration preceding LVL (median 171%, range 69-267%), reflecting progenitor release during the procedure. In donors 1 and 3, the CD34+ cell yields decreased in the third bag to 53% and 42% of that collected in the first bag, whereas the progenitor cell yields in donors 2 and 4 were stable or rose during the procedure, achieving in the third bag 157% and 105% of the number of CD34+ cells collected in the first bag. Minor changes were found in the subsets of CD34+ cells, lymphocytes, and monocytes collected at different periods during a single harvest. LVL was well tolerated. Reversible thombocytopenia developed in all cases. No late effects attributable to LVL or G-CSF were found in the 4 donors and 16 other healthy individuals who have undergone LVL in our institution. We conclude that LVL is safe and maximizes PBPC yields for allogeneic transplantation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1061-6128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-31
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9131441-Adult,
pubmed-meshheading:9131441-Blood Donors,
pubmed-meshheading:9131441-Cell Division,
pubmed-meshheading:9131441-Female,
pubmed-meshheading:9131441-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:9131441-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:9131441-Hematopoietic Stem Cells,
pubmed-meshheading:9131441-Histocompatibility Testing,
pubmed-meshheading:9131441-Humans,
pubmed-meshheading:9131441-Leukapheresis,
pubmed-meshheading:9131441-Leukocyte Count,
pubmed-meshheading:9131441-Leukocyte Transfusion,
pubmed-meshheading:9131441-Male
|
pubmed:year |
1997
|
pubmed:articleTitle |
Large volume leukapheresis maximizes the progenitor cell yield for allogeneic peripheral blood progenitor donation.
|
pubmed:affiliation |
Department of Hematology, Heinrich Heine University Düsseldorf, Germany.
|
pubmed:publicationType |
Journal Article
|